A natural product, apigenin, reduced AXL expression in ovarian cancer cell lines without affecting IL6 production and STAT3 phosphorylation [75], suggesting the selectivity of the STAT proteins in the regulation of AXL expression. This evidence concerns the gene STAT3 and ovarian carcinoma.